EA
Emerald Advisers’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,246
| Closed | -$158K | – | 256 |
|
2025
Q1 | $158K | Sell |
9,246
-235,312
| -96% | -$4.02M | 0.01% | 213 |
|
2024
Q4 | $6.06M | Sell |
244,558
-5,481
| -2% | -$136K | 0.23% | 108 |
|
2024
Q3 | $7.13M | Sell |
250,039
-38,525
| -13% | -$1.1M | 0.28% | 105 |
|
2024
Q2 | $7.62M | Sell |
288,564
-14,225
| -5% | -$376K | 0.32% | 100 |
|
2024
Q1 | $9.78M | Sell |
302,789
-3,476
| -1% | -$112K | 0.39% | 95 |
|
2023
Q4 | $12.9M | Buy |
+306,265
| New | +$12.9M | 0.55% | 73 |
|
2021
Q1 | – | Sell |
-603,670
| Closed | -$27.9M | – | 277 |
|
2020
Q4 | $27.9M | Buy |
603,670
+62,606
| +12% | +$2.89M | 0.93% | 40 |
|
2020
Q3 | $19M | Buy |
+541,064
| New | +$19M | 0.78% | 53 |
|